Beximco Pharmaceuticals Limited (AIM:BXP)
London flag London · Delayed Price · Currency is GBP · Price in GBX
39.50
-0.40 (-1.01%)
Jul 28, 2025, 4:35 PM GMT+1

Beximco Pharmaceuticals Company Description

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.

It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids.

The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Beximco Pharmaceuticals Limited
CountryBangladesh
Founded1976
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,122
CEOIqbal Ahmed

Contact Details

Address:
19 Dhanmondi R/A
Dhaka, 1205
Bangladesh
Phone880 2 5861 1001
Websitebeximcopharma.com

Stock Details

Ticker SymbolBXP
ExchangeLondon Stock Exchange AIM
Fiscal YearJuly - June
Reporting CurrencyBDT
ISIN NumberUS0885792061
SIC Code2834

Key Executives

NamePosition
Iqbal AhmedChief Executive Officer
Mohammad NawazChief Financial Officer
S. M. RezaChief Operating Officer